Prosecution Insights
Last updated: April 19, 2026

Legend Biotech Usa Inc.

3 pending office actions

Portfolio Summary

3
Total Pending OAs
1
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18284275 FUSION PROTEINS AND USES THEREOF LEE, YIE CHIA 1642 Non-Final OA Sep 26, 2023
17740665 METHODS OF MINIMIZING NEUROTOXICITY ASSOCIATED WITH CHIMERIC ANTIGEN RECEPTOR (CAR) T CELL THERAPY BATES, KEENAN ALEXANDER 1631 Non-Final OA May 10, 2022
17164125 CHIMERIC ANTIGEN RECEPTORS BASED ON SINGLE-DOMAIN ANTIBODIES AND METHODS OF USE THEREOF DUFFY, BRADLEY 1643 Final Rejection Feb 01, 2021

Managing Legend Biotech Usa Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month